These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 26597651)
1. Subclonal heterogeneity in chronic lymphocytic leukaemia: revealing the importance of the lymphoid tumour microenvironment. Apollonio B; Ramsay AG Br J Haematol; 2016 Jan; 172(1):7-8. PubMed ID: 26597651 [No Abstract] [Full Text] [Related]
2. Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments. Del Giudice I; Marinelli M; Wang J; Bonina S; Messina M; Chiaretti S; Ilari C; Cafforio L; Raponi S; Mauro FR; Di Maio V; De Propris MS; Nanni M; Ciardullo C; Rossi D; Gaidano G; Guarini A; Rabadan R; Foà R Br J Haematol; 2016 Feb; 172(3):371-383. PubMed ID: 26597680 [TBL] [Abstract][Full Text] [Related]
3. Targeted resequencing for analysis of clonal composition of recurrent gene mutations in chronic lymphocytic leukaemia. Jethwa A; Hüllein J; Stolz T; Blume C; Sellner L; Jauch A; Sill M; Kater AP; te Raa GD; Geisler C; van Oers M; Dietrich S; Dreger P; Ho AD; Paruzynski A; Schmidt M; von Kalle C; Glimm H; Zenz T Br J Haematol; 2013 Nov; 163(4):496-500. PubMed ID: 24032483 [TBL] [Abstract][Full Text] [Related]
4. Clonal evolution in chronic lymphocytic leukemia: impact of subclonality on disease progression. Sutton LA; Rosenquist R Expert Rev Hematol; 2015 Feb; 8(1):71-8. PubMed ID: 25345442 [TBL] [Abstract][Full Text] [Related]
5. Chronic lymphocytic leukaemia genomics and the precision medicine era. Ghamlouch H; Nguyen-Khac F; Bernard OA Br J Haematol; 2017 Sep; 178(6):852-870. PubMed ID: 28444740 [TBL] [Abstract][Full Text] [Related]
9. Karyotypes of 33 patients with clonal aberrations in chronic lymphocytic leukaemia. Review of 216 abnormal karyotypes in chronic lymphocytic leukaemia. Huret JL; Mossafa H; Brizard A; Dreyfus B; Guilhot F; Xue XQ; Babin P; Tanzer J Ann Genet; 1989; 32(3):155-9. PubMed ID: 2817776 [TBL] [Abstract][Full Text] [Related]
10. Identification of recurrent truncated DDX3X mutations in chronic lymphocytic leukaemia. Ojha J; Secreto CR; Rabe KG; Van Dyke DL; Kortum KM; Slager SL; Shanafelt TD; Fonseca R; Kay NE; Braggio E Br J Haematol; 2015 May; 169(3):445-8. PubMed ID: 25382417 [No Abstract] [Full Text] [Related]
11. [Pathogenesis of chronic lymphocytic leukemia]. Fukuda T Rinsho Ketsueki; 2015 Mar; 56(3):261-8. PubMed ID: 25876778 [TBL] [Abstract][Full Text] [Related]
12. Bi-clonal disease in patients with chronic lymphocytic leukaemia as detected by analysing IGHV mutation status. Sheikholeslami MR; Ma W; Uyeji J; Tornyos K; Cone L; Mamus S; Albitar M Br J Haematol; 2007 Nov; 139(3):507-9. PubMed ID: 17868045 [No Abstract] [Full Text] [Related]
13. Genetic evolution in chronic lymphocytic leukaemia. Delgado J; Villamor N; López-Guillermo A; Campo E Best Pract Res Clin Haematol; 2016 Mar; 29(1):67-78. PubMed ID: 27742073 [TBL] [Abstract][Full Text] [Related]
14. The impact of molecular cytogenetics on chronic lymphoid leukaemia. Brito-Babapulle V; Garcia-Marco J; Maljaie SH; Hiorns L; Coignet L; Conchon M; Catovsky D Acta Haematol; 1997; 98(4):175-86. PubMed ID: 9401494 [TBL] [Abstract][Full Text] [Related]
15. Utilization of next generation sequencing identifies potentially actionable mutations in chronic lymphocytic leukaemia. Wang J; Morrissette J; Lieberman DB; Timlin C; Schuster SJ; Mato AR Br J Haematol; 2018 Jan; 180(2):299-301. PubMed ID: 27714764 [No Abstract] [Full Text] [Related]
16. A case of concomitant chronic lymphocytic leukaemia and hairy cell leukaemia evaluated for IGHV-D-J rearrangements and BRAF-V600E mutation: lack of evidence for a common origin. Cavalli M; Ilari C; Del Giudice I; Marinelli M; Della Starza I; De Propris MS; De Novi LA; Nunes V; Cafforio L; Raponi S; Mancini F; Mauro FR; Tiacci E; Falini B; Guarini A; Foà R Br J Haematol; 2016 Jul; 174(2):329-31. PubMed ID: 26455504 [No Abstract] [Full Text] [Related]
17. [Prognostic factors in chronic lymphocytic leukaemia: contribution of recent biological markers]. Evrard S; Gaussem P; Helley D; Darnige L Ann Biol Clin (Paris); 2005; 63(6):589-97. PubMed ID: 16330377 [TBL] [Abstract][Full Text] [Related]
18. Subclonal heterogeneity sheds light on the transformation trajectory in IGLV3-21 Paschold L; Simnica D; Brito RB; Zhang T; Schultheiß C; Dierks C; Binder M Blood Cancer J; 2022 Mar; 12(3):49. PubMed ID: 35354800 [No Abstract] [Full Text] [Related]
19. Incidence of the BRAF V600E mutation in chronic lymphocytic leukaemia and prolymphocytic leukaemia. Langabeer SE; Quinn F; O'Brien D; McElligott AM; Kelly J; Browne PV; Vandenberghe E Leuk Res; 2012 Apr; 36(4):483-4. PubMed ID: 22230299 [TBL] [Abstract][Full Text] [Related]
20. The genomic landscape of chronic lymphocytic leukaemia: biological and clinical implications. Strefford JC Br J Haematol; 2015 Apr; 169(1):14-31. PubMed ID: 25496136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]